OncoCyte Corporation
NASDAQ:OCX
3.1 (USD) • At close October 28, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | OncoCyte Corporation |
Symbool | OCX |
Munteenheid | USD |
Prijs | 3.1 |
Beurswaarde | 52,189,120 |
Dividendpercentage | 0% |
52-weken bereik | 2.08 - 4.34 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Joshua Riggs |
Website | https://oncocyte.com |
An error occurred while fetching data.
Over OncoCyte Corporation
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)